Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
Asian Pulse Oximeters Asian Pulse Oximeters
The Asian Pulse Oximeters market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA). The market is clinched at $80.1 million in 2013 and is expected to reach a value of $177.8 million in 2018, with a CAGR of 17.3% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report.
Upcoming
North American Proton Radiotherapy Systems Market North American Proton Radiotherapy Systems Market
The North American Proton Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $106.6 million in 2013 and expected to be $122.1 million by 2018, growing at a CAGR of 2.7%. The Proton Radiotherapy Systems Market analyzes the market of devices by 2 segments such as Cyclotron for proton therapy, and Synchrotron for proton therapy. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc.
Upcoming
Asian Pre-clinical Imaging Market Asian Pre-clinical Imaging Market
The Asian Pre-Clinical Devices Market, mainly driven by aging population, technological advancements, low cost of the treatment, and increasing prevalence to various diseases such as cancer and heart related disorders. The report “Asian Pre-Clinical Devices Market forecast, 2008-2018 “analyzes the market of devices majorly on the basis of technologies. Geographically, the market is mainly segmented into Japan, China, India, and Rest of Asia-Pacific (APAC). The report also provides an extensive competitive landscaping of companies operating in this market.  
Upcoming
North American Non-Knowledge based Clinical decision support systems (CDSS) North American Non-Knowledge based Clinical decision support systems (CDSS)
The North American Non-Knowledge based Clinical decision support systems (CDSS) market was valued at $17.0 million in 2012, and is expected to reach $20.0 million by 2018, at a CAGR of 2.1%.The non-knowledge based CDSS market can be segmented by geography, application, technology, product, and end-user. Deep dive analysis of key market players have also been considered in this report.  
Upcoming
European Brachytherapy European Brachytherapy
The European Brachytherapy Market was pegged at $50 million in 2013 and expected to be $54 million by 2018. The report “European Brachytherapy Market forecast, 2010-2018 “analyzes the market of devices by segments such as High Dose Rate Brachytherapy, Pulsed Dose Rate Brachytherapy, and Permanent Seed Brachytherapy. The main companies operating in European Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
Asia-Pacific Brachytherapy Asia-Pacific Brachytherapy
The Asia-Pacific Radiation Ablation Market was pegged at $32 million in 2013 and expected to be $38 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Asia-Pacific brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
Americas Brachytherapy Americas Brachytherapy
The American Brachytherapy Market was pegged at $129 million in 2013 and expected to be $146 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
European Pre-clinical Imaging Devices Market European Pre-clinical Imaging Devices Market
The European Pre-Clinical Imaging Devices Market, mainly driven by aging population, technological advancements, low cost of the treatment, and increasing prevalence to various diseases such as cancer and heart related disorders. The report “European Pre-Clinical Imaging Devices Market forecast, 2008-2018 “analyzes the market of devices majorly on the basis of technologies. Geographically, the European Pre-Clinical Imaging Devices Market is mainly segmented into U.K., Germany, France, Italy, Spain, and Rest of Europe. The report European Pre-Clinical Imaging Devices Market also provides an extensive competitive landscaping of companies operating in this market.  
Upcoming
European Proton Radiotherapy Systems Market European Proton Radiotherapy Systems Market
The European Proton Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $82.1 million in 2013 and expected to be $95.0 million by 2018, growing at a CAGR of 3.0%. The Proton Radiotherapy Systems Market analyzes the market of devices by 2 segments such as Cyclotron for proton therapy, and Synchrotron for proton therapy. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc.
Upcoming
North American Pre-clinical Imaging Devices Market North American Pre-clinical Imaging Devices Market
The North American Pre-Clinical Imaging Devices Market, mainly driven by aging population, technological advancements, low cost of the treatment, and increasing prevalence to various diseases such as cancer and heart related disorders. The report “North American Pre-Clinical Imaging Devices Market forecast, 2008-2018 “analyzes the market of devices majorly on the basis of technologies. Geographically, the market is mainly segmented into U.S., Canada, and Mexico. The report North American Pre-Clinical Imaging Devices Market also provides an extensive competitive landscaping of companies operating in this market.
Upcoming
European Non-Knowledge based Clinical decision support systems (CDSS) European Non-Knowledge based Clinical decision support systems (CDSS)
The European non-knowledge based clinical decision support systems (CDSS) market was estimated at $3 million in 2012, and is expected to reach $3.4 million by 2018, at a CAGR of 2.2%.The non-knowledge based CDSS market can be segmented by geography, application, technology, product, and end-user. Deep dive analysis of key market players are also considered in this report.
Upcoming
Asian Non-Knowledge based Clinical decision support systems (CDSS) Asian Non-Knowledge based Clinical decision support systems (CDSS)
The Asian non-knowledge based CDSS market was valued at $3 million in 2012, and is projected to reach $3.4 million by 2018, at a CAGR of 2.4%.The non-knowledge based CDSS market is segmented by geography, application, technology, product, and end-user. Deep dive analysis of key market players have also been considered in this report.
Upcoming
Asian Proton Radiotherapy Systems Market Asian Proton Radiotherapy Systems Market
The Asian Proton Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $32.7 million in 2013 and expected to be $46.6 million by 2018, growing at a CAGR of 7.4%. The Proton Radiotherapy Systems Market analyzes the market of devices by 2 segments such as Cyclotron for proton therapy, and Synchrotron for proton therapy. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc.
Upcoming
North American Polysomnography (PSG) Device North American Polysomnography (PSG) Device
The North American Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA). The market is clinched at $1.3 billion in 2013 and is expected to reach a value of $2.5 billion in 2018, with a CAGR of 14.7% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report.
Upcoming
North American E-Prescribing (e-Rx) North American E-Prescribing (e-Rx)
The North American E-Prescribing (e-Rx), mainly driven by growing popularity of e-priscripttion, was pegged at $84.43 million in 2013 and expected to be $328.14 million by 2018, growing at a CAGR of 31.2% from 2013 to 2018. E-Prescribing (e-Rx) systems market segmentation by products (Stand-alone and integrated), deployment modes( Licensed(On-premise, Web-hosted, Cloud hosted), usage mode(PC-based and Hand Held), components( Hardware, Software and Services), end users ( Hospitals and Office based physicians) , and geography. The major companies operating in E-Prescribing (e-Rx), market and extensively covered in the report are Cerner Corporation (U.S.), Allscripts (U.S), Quality Systems Inc. (U.S.), Emdeon (U.S.), and Athenahealth (U.S.), eclinical Works(U.S.), Practice Fusion (U.S.)
Upcoming
European BioProduction Market European BioProduction Market
The European BioProduction Market, mainly driven by increasing in-vitro research activities, increasing demand for vaccines and cellular medicine. The report “European BioProduction Market forecast, 2008-2018 “analyzes the market by 5 main segments such as tissue engineering, cell culture, protein engineering, biomaterials, and micro-reactor. Geographically, the European BioProduction Market is mainly segmented into U.K., Germany, France, Italy, Spain, and Rest of Europe. The report European BioProduction Market  also provides an extensive competitive landscaping of companies operating in this market.
Upcoming
European E-Prescribing (e-Rx) European E-Prescribing (e-Rx)
The European E-Prescribing (e-Rx), mainly driven by growing popularity of e-priscripttion, was pegged at $163.62 million in 2013 and expected to be $468.0 million by 2018, growing at a CAGR of 23.4% from 2013 to 2018. E-Prescribing (e-Rx) systems  market  segmentation segmentation by products (Stand-alone and integrated), deployment modes( Licensed(On-premise, Web-hosted, Cloud hosted), usage mode(PC-based and Hand Held), components( Hardware, Software and Services), end users ( Hospitals and Office based physicians) , and geography. The major companies operating in E-Prescribing (e-Rx), market and extensively covered in the report are Cerner Corporation (U.S.), Allscripts (U.S), Quality Systems Inc. (U.S.), Emdeon (U.S.), and Athenahealth (U.S.), eclinical Works(U.S.), Practice Fusion (U.S.)
Upcoming
Asian E-Prescribing (e-Rx) Asian E-Prescribing (e-Rx)
The Asian E-Prescribing (e-Rx), mainly driven by growing popularity of e-priscripttion, was pegged at $71.49  million in 2013 and expected to be $232.22 million by 2018, growing at a CAGR of 26% from 2013 to 2018. E-Prescribing (e-Rx) systems market segmentation by products (Stand-alone and integrated), deployment modes( Licensed(On-premise, Web-hosted, Cloud hosted), usage mode(PC-based and Hand Held), components( Hardware, Software and Services), end users ( Hospitals and Office based physicians) , and geography. The major companies operating in E-Prescribing (e-Rx), market and extensively covered in the report are Cerner Corporation (U.S.), Allscripts (U.S), Quality Systems Inc. (U.S.), Emdeon (U.S.), and Athenahealth (U.S.), eclinical Works(U.S.), Practice Fusion (U.S.)
Upcoming
European Polysomnography (PSG) Device European Polysomnography (PSG) Device
The European Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA). The market is clinched at $526.2 million in 2013 and is expected to reach a value of $1.0 billion in 2018, with a CAGR of 14.2% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report.
Upcoming
Asian Polysomnography (PSG) Device Asian Polysomnography (PSG) Device
The Asian Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA). The market is clinched at $292.7 million in 2013 and is expected to reach a value of $611.3 million in 2018, with a CAGR of 15.9% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report.
Upcoming
2987 reports | Show
Connect With Us
US/CAN : +1-888-502-0539